Tectonic Therapeutic, Inc.
NASDAQ:TECXBiotechnology
-$0.29 today
- Market cap
- $411.32M
- Beta
- 1.22
- P/E (TTM)
- -6.7
- EPS (TTM)
- -$4.45
Volume 0.17M
Average 0.20M
TECX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Tectonic Therapeutic, Inc.NASDAQ: TECX
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was $0, compared with $2K a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (96K) USD
- Year-over-year change
- -1166.7%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (96K) | -1166.7% |
| FY2024 | 2024-12-31 | 9K | +181.8% |
| FY2023 | 2023-12-31 | (11K) | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Accumulated OCI vs competitors
How TECX compares with its peers on the latest reported figures
- TECX's Mar 2026 Accumulated OCI of $0 is the 2nd highest of the 4 companies compared; the peer median is -$2.05M.
- Its year-over-year change of -100.0% is the highest of 3, against a peer median of -848.5%.
- Accumulated OCI amounts to 0.0% of total assets for TECX, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
GENBGenerate Biomedicines, Inc. | Mar 2026 | $24K | — | — | 0.0% |
TECXTectonic Therapeutic, Inc. | Mar 2026 | $0 | -100.0% | — | 0.0% |
SEPNSepterna, Inc. | Sep 2026 | -$2.05M | -645.3% | — | 0.3% |
| Jun 2026 | -$3.45M | -1051.7% | — | 0.2% | |
| Peer median (excluding TECX) | -$2.05M | -848.5% | — | 0.2% | |
Competitors are the stored peer set for TECX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.06M | 35.97M | 28.77M | 141.24M | 253.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 557K | 1.08M | 2.12M | 5.62M | 3.56M |
| Total Current Assets | 28.62M | 37.04M | 30.88M | 146.86M | 257.36M |
| Property, Plant & Equipment (Net) | 3.66M | 9.55M | 7.23M | 5.31M | 2.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 587K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 599K | 613K | 1.29M | 156K | 1.13M |
| Total Non-current Assets | 4.26M | 10.17M | 8.52M | 6.05M | 3.68M |
| Total Assets | 32.88M | 47.21M | 39.4M | 152.91M | 261.04M |
| Account Payables | 1.81M | 574K | 409K | 976K | 1.09M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.76M | 2.66M | 33.37M | 3.59M | 4.11M |
| Total Current Liabilities | 4.12M | 7.84M | 40.89M | 11.61M | 9.67M |
| Long-term Debt | 0 | 0 | 0 | 0 | 43K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 43.02M | 80.68M | 80.63M | 0 | 0 |
| Total Non-current Liabilities | 43.72M | 85.03M | 83.15M | 519K | 43K |
| Total Liabilities | 47.84M | 92.86M | 124.04M | 12.13M | 9.71M |
| Common Stock | 0 | 0 | 0 | 2K | 2K |
| Retained Earnings | (15.6M) | (47.78M) | (90.6M) | (148.59M) | (222.74M) |
| Accumulated OCI | 0 | 0 | (11K) | 9K | (96K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (14.96M) | (45.65M) | (84.64M) | 140.78M | 251.33M |
| Total Debt | 1.06M | 5.79M | 4.34M | 3.3M | 1.28M |
| Net Debt | (27.01M) | (30.17M) | (24.43M) | (137.94M) | (252.52M) |
Tectonic Therapeutic, Inc.
NASDAQ:TECX
Intrinsic Alpha fair value
Locked
Current Price
$21.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.